Huma Therapeutics Ltd today announced the completion of its Series C funding round with financing of around $130 million.
Leaps by Bayer and Hitachi Ventures led the round, which also saw new strategic and financial investors become shareholders.
Samsung Next, Sony Innovation Fund by IGV, Unilever Ventures and HAT Technology & Innovation Fund by HAT, as well as individuals Nikesh Arora (...
